1. BhattacharyaA.
RastogiV.
TanM.
BurknerH. P.
Boston, MABoston Consulting GroupHow Asia Can Win in the New Global Era2017
2. Factors associated with multiple FDA review cycles and approval phase times;DiMasi;Drug Information J.,2009
3. FDA Has Encouraged Development But Needs to Clarify the Role of Draft Guidance and Develop Qualified Infectious Disease Product Guidance2017
4. ALS patients ask FDA to see risk their way;Haley;Pink Sheet,2013